Dr. Paul Greene graduated from MIT (BS ‘63), University of Connecticut Medical School (MD ‘80), and completed a fellowship in Movement Disorders at Columbia Presbyterian Medical Center (1985-1988). He became an attending in Movement Disorders at Columbia in 1988, left Columbia in 2014 to become an attending at Mt. Sinai School of Medicine from 2014 to 2019, and came to Yale in 2019. Dr. Greene has done clinical research in, published papers about, and lectured on a variety of movement disorders, including Parkinson’s disease and Parkinson’s-like diseases, idiopathic and secondary forms of dystonia, movement disorders in autism, and movement disorders in a variety of rare, genetic diseases. He participated in one of the first double-blind, placebo-controlled studies of fetal tissue transplants to try and treat Parkinson’s disease. He also was one of the early neurologists to use botulinum toxin injections for dystonia and other movement disorders and has written and lectured about the use of toxin injections to treat movement disorders. In addition to diagnosing and treating Parkinson’s disease and diseases causing the symptom dystonia, Dr. Greene is also happy to see patients with tremors, tics and Tourette syndrome, movement disorders caused by psychiatric medications, rapid jerks known as myoclonus, and other movement disorder symptoms.
Education & Training
- Board CertificationAB of Psychiatry & Neurology, Neurology (1990)